CPC A61K 31/17 (2013.01) [A61K 9/0014 (2013.01); A61K 9/06 (2013.01); A61K 31/573 (2013.01); A61K 31/58 (2013.01)] | 4 Claims |
1. A method of formulating a topical composition for treatment of a hyperkeratotic skin condition, the method comprising:
combining contents of a compounded capsule with a corticosteroid cream to formulate a topical composition for application to a skin area affected by hyperkeratosis,
wherein the contents of the capsule comprise urea bulk powder, and
wherein the step of combining the contents of the compounded capsule with the corticosteroid cream comprises stirring or folding the urea bulk powder into the corticosteroid cream,
wherein the corticosteroid cream comprises Clobetasol Propionate Cream, 0.05%, comprising cetyl alcohol, citric acid, glycol stearate, lanolin oil, methylparaben, PEG-8 stearate, polysorbate 60, propylene glycol, propylparaben, purified water, sodium citrate, stearyl alcohol, and white petrolatum, and
wherein the topical composition comprises between approximately 2.5% and approximately 50% urea by weight and between approximately 0.0250% and approximately 0.0488% clobetasol propionate by weight.
|